SEC Form 4 · accession 0001179110-16-018873
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
bng0, LLC
10% Owner
Period of report
Feb 8, 2016
Accepted (ET)
Feb 10, 2016 · 10:20 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 8, 2016 | C | 2,649,572 | $0.00 | A | 2,649,572 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Preferred StockF1 | — | Feb 8, 2016 | C | 6,888,888 | D | — | — | Common Stock | 2,649,572 | 0 | D |
Explanation of responses
- F1The Series B Preferred Stock converted into Common Stock on a 2.6-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Remarks
This report is one of two reports, each on a separate on Form 4 by bng0,LLC and Boris Nikolic, which relate to the same securities and the same transaction.